- The volume of blood collected in North America every year for medical purposes is staggering. In the United States alone, estimates show that over 18 mn units of blood is transfused annually to treat hematologic diseases.
- Tests on blood samples are vital to the timely diagnosis of potentially life-threatening diseases such as dengue, thalassemia, and even certain types of cancer. This is causing an uptick in the demand of blood collection tubes.
- The coverage of several diseases and conditions under new reimbursement plans in the United States has caused a spurt in the number of diagnostic tests conducted here annually, subsequently leading to higher demand for blood collection tubes.
- By type, the blood collection tubes market can be divided into rapid serum tubes, plasma separating tubes, heparin tubes, serum separating tubes, and other tubes. Of these, North America sees the highest demand for serum separating tubes. Canada and the United States are the two key markets in North America, of which the United States blood collection tubes market generates the highest revenue.
- There is a growing demand for tubes that are compatible with automated blood collection processes and more advanced screening tests. This is prompting manufacturers to improve the design of their existing products and bring easy-to-use blood collection tubes to the market.